Mitesh

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 10 May 2023) has been published and includes articles on: Direct-acting oral anticoagulants (DOACs): paediatric formulations; reminder of dose adjustments in patients with renal impairment Glucose solutions: recommendations to minimise the risks associated with the accidental use of glucose solutions [...]

The post MHRA Drug Safety Update May 2023 appeared first on PSNC Website.

Class 4 Medicines Defect Information: Buccolam 10mg Oromucosal solution (Orifarm UK Ltd) Drug alert number: EL (23)A/18 Date issued: 22 May 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Product name: Buccolam 10mg Oromucosal solution (Orifarm UK Ltd) PLGB 45985/0272 Batch No Expiry Date [...]

The post MHRA Class 4 Medicines Defect Information: Buccolam 10mg Oromucosal solution (Orifarm UK Ltd) appeared first on PSNC Website.

Update 01/09/23 – The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocol (SSP) for Utrogestan® 100mg capsules (SSP056) was due to expire 1 September 2023 but has been further extended to Friday 29 September 2023. Update 09/06/23 – The Department of Health and Social Care (DHSC) has [...]

The post Extension to Utrogestan® 100mg capsules SSP (SSP056) appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of the following products are now available to meet normal demand: Sandrena® 0.5mg gel sachets Sandrena® 1mg gel sachets Lipitor® 10mg chewable tablets Phenoxymethylpenicillin 125mg/5ml oral solution Phenoxymethylpenicillin 125mg/5ml oral solution sugar free Phenoxymethylpenicillin 250mg/5ml oral solution Phenoxymethylpenicillin 250mg/5ml oral solution sugar free [...]

The post Expiry of fourteen SSPs appeared first on PSNC Website.

In light of surveillance data indicating that circulation of influenza in the community has returned to baseline levels, the Department of Health and Social Care has published an alert to inform prescribers working in primary care and pharmacy teams that antiviral medicines should no longer be prescribed.  Community pharmacists should no longer supply antiviral medicines [...]

The post End of antiviral medicine prescribing for 2022/23 influenza season appeared first on PSNC Website.